# Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder

> **NCT00131339** · NA · COMPLETED · sponsor: **Hartford Hospital** · enrollment: 40 (—)

## Conditions studied

- Panic Disorder

## Interventions

- **BEHAVIORAL:** Cognitive behavioral therapy
- **DRUG:** D-cycloserine

## Key facts

- **NCT ID:** NCT00131339
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 40 (—)
- **Last updated:** 2009-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00131339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00131339, "Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00131339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*